{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-21-145714","form_type":"8-K","ticker":"REPL","cik":"0001737953","company_name":"Replimune Group, Inc.","filed_at":"2021-12-02T23:59:59+00:00","discovered_at":"2026-05-14T18:04:13.893478+00:00","generated_at":"2026-06-28T04:12:27.156547+00:00","sec_items":["5.02","7.01","9.01"],"event_type":"leadership","sentiment":"neutral","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Replimune appoints Christy Oliger to Board effective Dec 1, 2021","bullets":["Oliger appointed to Board, increasing size to 11; also joins Audit and R&D Committees.","She brings ~30 yrs pharma/biotech experience, most recently SVP Oncology at Genentech.","Receives $40k annual Board cash retainer, plus $7.5k Audit, $6k R&D; stock option for 33k shares at $28.01.","Option vests 25% on 1st anniversary, then monthly over 24 months.","Appointment effective Dec 1, 2021; will stand for election at 2022 annual meeting."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-21-145714","json":"https://secwatch.observer/filing/0001104659-21-145714.json","markdown":"https://secwatch.observer/filing/0001104659-21-145714.md","text":"https://secwatch.observer/filing/0001104659-21-145714.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921145714/0001104659-21-145714-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921145714/tm2134404d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-28T04:12:27.156547+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"af2394560e","claim":"Christy Oliger was appointed as Director at Replimune Group, Inc..","evidence_excerpt":"the Board of Directors of the Company (the “ Board ”) increased the size of the Board from ten members to eleven and filled the newly created vacancy on the Board by appointing Christy Oliger as a director of the Company.","evidence_source":"SEC 8-K Item 5.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1737953/000110465921145714/0001104659-21-145714-index.htm","confidence":0.95,"family_label":"Executive change","details":[{"label":"Action","value":"appointed"},{"label":"Role","value":"Director"}],"fact_type":"executive_change"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}